SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Stefanie Schrauwen, Jeroen Depreeuw, Lieve Coenegrachts, Els Hermans, Diether Lambrechts, Frédéric Amant, Dual blockade of PI3K/AKT/mTOR (NVP-BEZ235) and Ras/Raf/MEK (AZD6244) pathways synergistically inhibit growth of primary endometrioid endometrial carcinoma cultures, whereas NVP-BEZ235 reduces tumor growth in the corresponding xenograft models, Gynecologic Oncology, 2015, 138, 1, 165

    CrossRef

  2. 2
    Matthias S. Matter, Thomas Decaens, Jesper B. Andersen, Snorri S. Thorgeirsson, Targeting the mTOR pathway in hepatocellular carcinoma: Current state and future trends, Journal of Hepatology, 2014, 60, 4, 855

    CrossRef

  3. 3
    Kerstin Kampa-Schittenhelm, Michael Heinrich, Figen Akmut, Katharina Rasp, Barbara Illing, Hartmut Döhner, Konstanze Döhner, Marcus Schittenhelm, Cell cycle-dependent activity of the novel dual PI3K-MTORC1/2 inhibitor NVP-BGT226 in acute leukemia, Molecular Cancer, 2013, 12, 1, 46

    CrossRef

  4. 4
    Yi-Hsiang Huang, Han-Chieh Lin, The role of mTOR inhibitors in the treatment of hepatocellular carcinoma, Liver International, 2013, 33, 8